Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor and the kidney.

D Schlondorff, R Neuwirth

    The American Journal of Physiology
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Platelet-activating factor (PAF) is a phospholipid involved in various biological responses. This study explores PAF

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.

    Cancer chemotherapy and pharmacology·2017
    Same author

    [Outcomes of catheter ablation of atrial fibrillation in patients over 65 years of age].

    Vnitrni lekarstvi·2013
    Same author

    [A comparison of two methods of long-term external ECG telemonitoring in patients after ablation for atrial fibrillation].

    Vnitrni lekarstvi·2012
    Same author

    [Catheter ablation of atrio-ventricular accessory pathways in the era of ablation therapy of complex arrhythmias: a changing perspective for oncoming generation of electrophysiologists].

    Vnitrni lekarstvi·2012
    Same author

    Compartment specific expression of dendritic cell markers in human glomerulonephritis.

    Kidney international·2008
    Same author

    [Recurrent arrhythmias after catheter ablation of originally paroxysmal atrial fibrillation and results of repeat ablation].

    Vnitrni lekarstvi·2008
    Same journal

    Blood coagulation in fish.

    The American journal of physiology·2011
    Same journal

    Renal tubular reabsorption, metabolic utilization and isomeric fractionation of lactic acid in the dog.

    The American journal of physiology·2010
    Same journal

    The inactivation of placental toxin by human serum.

    The American journal of physiology·2010
    Same journal

    Adrenal function following ovariectomy in the rat.

    The American journal of physiology·2010
    Same journal

    Capillary permeability; perfusion of frog and guinea pig hind limbs.

    The American journal of physiology·2010
    Same journal

    Evaluation of protective measures against sunburn.

    The American journal of physiology·2010
    See all related articles

    Area of Science:

    • Biochemistry
    • Cell Biology
    • Physiology

    Background:

    • Platelet-activating factor (PAF) is a class of phospholipids with a defined structure.
    • PAF is produced by various cells upon stimulation.
    • PAF synthesis involves phospholipase A2 activation and acetylation of lyso-PAF.

    Purpose of the Study:

    • To investigate the role of PAF in renal physiology and pathophysiology.
    • To understand the mechanisms of PAF production and inactivation in the kidney.
    • To explore the interactions of PAF with other mediators in renal function.

    Main Methods:

    • Review of existing literature on PAF synthesis, inactivation, and biological activities.
    • Analysis of studies involving PAF administration in isolated kidney preparations, glomeruli, and cultured cells.

    Related Experiment Videos

  • Examination of PAF's effects on renal blood flow, glomerular filtration, and electrolyte excretion.

    • Main Results:

    • PAF induces platelet and leukocyte aggregation, vascular permeability changes, and affects cardiac output and blood pressure.
    • In the kidney, PAF can decrease blood flow, glomerular filtration, and fluid and electrolyte excretion.
    • Intrarenal PAF administration can lead to glomerular platelet/leukocyte accumulation and mild proteinuria.
    • PAF stimulates prostaglandin production in renal cells and causes mesangial cell contraction.
    • Kidney cells, glomeruli, and mesangial cells can produce PAF upon stimulation.

    Conclusions:

    • PAF plays a significant role in renal physiology and pathophysiology.
    • Further research is needed to fully elucidate PAF's complex interactions with prostaglandins and leukotrienes in the kidney.
    • The localized action of PAF as an autocoid may complicate the understanding of its systemic effects.